Cachexia Treatment Market

Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.
Cachexia Treatment Market contains market size and forecasts of Cachexia Treatment in Global, including the following market information:
Global Cachexia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cachexia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Weight Loss Stabilizers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cachexia Treatment include Alder Biopharmaceuticals Inc., GTx Inc., Helsinn Group, Merck & Co. Inc., Bristol-Myers Squibb Company, Helsinn Healthcare S.A., PsiOxus, Purdue Pharma L.P. and Eterna Zentaris Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cachexia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cachexia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cachexia Treatment Market Segment Percentages, by Type, 2021 (%)
Weight Loss Stabilizers
Appetite Stimulants
Progestogens
Corticosteroids
Combination therapies
Others
Global Cachexia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cachexia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online
Global Cachexia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cachexia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cachexia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cachexia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alder Biopharmaceuticals Inc.
GTx Inc.
Helsinn Group
Merck & Co. Inc.
Bristol-Myers Squibb Company
Helsinn Healthcare S.A.
PsiOxus
Purdue Pharma L.P.
Eterna Zentaris Inc.
Aphios Corporation
Neurim
Novartis AG
SkyePharma